SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Imclone systems (IMCL)
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
2515 89 0 IMCL
Emcee:  Deeber Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2390I saw some report the other day that IMCL earnings via Merck would only amount t613-3/28/2003
2389News is out from Merck and it is very positive.... " "In our oncoloArthur Radley-3/28/2003
2388Didn't merckkg already whisper as much to its friends weeks ago? Thus the keokalani'nui-3/27/2003
2387The news today indicates that tomorrow is D-day for IMCL....appears Merck will rArthur Radley-3/27/2003
2386Cacaito, I think the drug works. Very, very well. But what I do not know is theopalapril-3/26/2003
2385It is true, the drug should be evaluated on its own properties, not by the collaCacaito-3/25/2003
2384TD, I hope that your investment with IMCL will play well. My point is that CacaMiljenko Zuanic-3/21/2003
2383Good morning, Miljenko! (See I'm trying to be nice...(:>) ) If I made anArthur Radley-3/21/2003
2382<<After being a harsh critic of Dr. "Waskal", ..>> As I rMiljenko Zuanic-3/20/2003
2381After being a harsh critic of Dr. "Waskal", I find it hard to believe Arthur Radley-3/20/2003
23808:55AM Imclone price target raised to $25 at Thomas Weisel (IMCL) 14.11: Thomas Arthur Radley-3/5/2003
2379ImClone to Offer Erbitux to Sickest Cancer Patients story.news.yahoo.combenchpress550-2/8/2003
2378NEW YORK, Dec 19 (Reuters) - German drugmaker Merck KGaA (Frankfurt:MRCG.F - Newtom pope-12/19/2002
2377The reference is from reading abstract in post 2374, I am trying to understand wCacaito-12/18/2002
2376Cacaito-- Could you kindly clarify your post. What's the source? How manyFred Levine-12/15/2002
2375Bye bye from the QQQ !!! confirmed and unconfirmed: ..."Thus far, 8 pts hCacaito-12/14/2002
2374510A: A Phase II Study of Erbitux (IMC-C225), an Epidermal Growth Factor ReceptMiljenko Zuanic-11/20/2002
2373Simple q - how will Erbitux work as a stand-alone if it doesn't work in conj613-11/19/2002
2372CEO Takes ImClone for a Walk Up the Street [TSCM] By Adam Feuerstein Senior WrDoc Bones-11/18/2002
2371Hi Fred-- Thanks for the info..I have tried to trade this one and I have been kMattB-11/15/2002
2370I read this as affirming the potential of IMCL's product line, esp Erbitux--Fred Levine-11/14/2002
2369Columnist on the Street.com mentioned a buy-out rumor from BMY at about 19. He cMattB-11/14/2002
2368FWIW-- From Yahoo thread-- >>... old-line, value manager Michael SteinbeFred Levine-11/13/2002
2367Nice move today, and nice upward drift from lows. My reading is that either thaFred Levine-11/13/2002
2366Associated Press ImClone Submits Trial Plans to FDA Fred Levine-10/31/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News